Sublethal caspase activation promotes generation of cardiomyocytes from embryonic stem cells. 2015

Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
Division of Cardiothoracic Surgery and Anesthesiology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Generation of new cardiomyocytes is critical for cardiac repair following myocardial injury, but which kind of stimuli is most important for cardiomyocyte regeneration is still unclear. Here we explore if apoptotic stimuli, manifested through caspase activation, influences cardiac progenitor up-regulation and cardiomyocyte differentiation. Using mouse embryonic stem cells as a cellular model, we show that sublethal activation of caspases increases the yield of cardiomyocytes while concurrently promoting the proliferation and differentiation of c-Kit+/α-actininlow cardiac progenitor cells. A broad-spectrum caspase inhibitor blocked these effects. In addition, the caspase inhibitor reversed the mRNA expression of genes expressed in cardiomyocytes and their precursors. Our study demonstrates that sublethal caspase-activation has an important role in cardiomyocyte differentiation and may have significant implications for promoting cardiac regeneration after myocardial injury involving exogenous or endogenous cell sources.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D000185 Actinin A protein factor that regulates the length of R-actin. It is chemically similar, but immunochemically distinguishable from actin. alpha-Actinin,Eu-Actinin,beta-Actinin,Eu Actinin,alpha Actinin,beta Actinin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053148 Caspase 3 A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA. CASP3,Apopain,Caspase-3,Pro-Caspase-3,Procaspase-3,Pro Caspase 3,Procaspase 3
D053453 Caspase 9 A long pro-domain caspase that contains a CASPASE RECRUITMENT DOMAIN in its pro-domain region. Caspase 9 is activated during cell stress by mitochondria-derived proapoptotic factors and by CARD SIGNALING ADAPTOR PROTEINS such as APOPTOTIC PROTEASE-ACTIVATING FACTOR 1. It activates APOPTOSIS by cleaving and activating EFFECTOR CASPASES. Apoptotic Protease Activating Factor 3,Caspase-9,ICE-LAP6 Protein,ICE-Like Apoptotic Protease 6,Pro-Caspase-9,Procaspase-9,ICE LAP6 Protein,ICE Like Apoptotic Protease 6,Pro Caspase 9,Procaspase 9

Related Publications

Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
November 2002, Herz,
Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
April 2024, Advanced biology,
Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
December 2013, Journal of cardiovascular translational research,
Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
January 2005, Methods in molecular medicine,
Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
January 2006, Handbook of experimental pharmacology,
Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
January 2011, Regenerative medicine,
Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
June 2006, Stem cells (Dayton, Ohio),
Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
October 2011, Acta pharmacologica Sinica,
Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
August 2016, Cardiovascular therapeutics,
Ivana Bulatovic, and Cristian Ibarra, and Cecilia Österholm, and Heng Wang, and Antonio Beltrán-Rodríguez, and Manuel Varas-Godoy, and Agneta Månsson-Broberg, and Per Uhlén, and András Simon, and Karl-Henrik Grinnemo
May 2003, Cardiovascular research,
Copied contents to your clipboard!